Trials / Terminated
TerminatedNCT00912509
Cross Linking for Treatment of Corneal Infection
A Prospective Randomized Double-masked Evaluation of Treatment Duration of the UVX System for Treating Infectious Keratitis
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Price Vision Group · Industry
- Sex
- All
- Age
- 14 Years
- Healthy volunteers
- Not accepted
Summary
This study is comparing 45 minute and 30 minute treatment durations with the UVX corneal cross linking system to treat corneal infections.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | riboflavin | riboflavin 0.1% is applied every 2 minutes for 30 minutes |
| DEVICE | UVX Light | UVX 365 nm wavelength light source is applied with continued application of riboflavin 0.1% |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2009-06-03
- Last updated
- 2017-11-22
- Results posted
- 2014-08-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00912509. Inclusion in this directory is not an endorsement.